Academic Journal
Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients
| العنوان: | Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients |
|---|---|
| المؤلفون: | Muller-Serieys, C, Bancal, C, Dombret, M C, Soler, P, Murciano, G, Aubier, M, Bergogne-Berezin, E |
| المصدر: | Antimicrobial Agents and Chemotherapy ; volume 36, issue 10, page 2099-2103 ; ISSN 0066-4804 1098-6596 |
| بيانات النشر: | American Society for Microbiology |
| سنة النشر: | 1992 |
| الوصف: | The pulmonary disposition of cefpodoxime was studied in 12 patients with pulmonary opacities after a single oral dose of 260 mg of cefpodoxime-proxetil, which is equivalent to 200 mg of cefpodoxime. Blood and lung tissue samples were collected during surgery, and bronchoalveolar lavage was carried out 3 h (group A) or 6 h (group B) after drug administration. Urea was used as an endogenous marker for measurement of the volume of epithelial lining fluid (ELF). Concentrations were measured by using a microbiological assay. The mean concentrations of cefpodoxime in plasma, ELF, and lung tissue were, respectively, 1.85 +/- 0.82 mg/liter, 0.22 +/- 0.13 mg/liter, and 0.89 +/- 0.80 mg/kg of body weight in group A and 1.40 +/- 1.25 mg/liter, 0.12 +/- 0.14 mg/liter, and 0.84 +/- 0.61 mg/kg in group B. Concentrations in lung parenchyma 6 h after dosing were at least equal to or above the MICs for 90% of the strains of most organisms commonly found in respiratory tract infections, whereas data for ELF suggest levels of drug insufficient to inhibit bacteria. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1128/aac.36.10.2099 |
| DOI: | 10.1128/AAC.36.10.2099 |
| الاتاحة: | http://dx.doi.org/10.1128/aac.36.10.2099 https://journals.asm.org/doi/pdf/10.1128/AAC.36.10.2099 |
| Rights: | https://journals.asm.org/non-commercial-tdm-license |
| رقم الانضمام: | edsbas.6A6D5847 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.6A6D5847 816 3 Academic Journal academicJournal 815.809631347656 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.6A6D5847&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => http://dx.doi.org/10.1128/aac.36.10.2099# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Muller-Serieys%2C+C%22">Muller-Serieys, C</searchLink><br /><searchLink fieldCode="AR" term="%22Bancal%2C+C%22">Bancal, C</searchLink><br /><searchLink fieldCode="AR" term="%22Dombret%2C+M+C%22">Dombret, M C</searchLink><br /><searchLink fieldCode="AR" term="%22Soler%2C+P%22">Soler, P</searchLink><br /><searchLink fieldCode="AR" term="%22Murciano%2C+G%22">Murciano, G</searchLink><br /><searchLink fieldCode="AR" term="%22Aubier%2C+M%22">Aubier, M</searchLink><br /><searchLink fieldCode="AR" term="%22Bergogne-Berezin%2C+E%22">Bergogne-Berezin, E</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Antimicrobial Agents and Chemotherapy ; volume 36, issue 10, page 2099-2103 ; ISSN 0066-4804 1098-6596 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => American Society for Microbiology ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 1992 ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => The pulmonary disposition of cefpodoxime was studied in 12 patients with pulmonary opacities after a single oral dose of 260 mg of cefpodoxime-proxetil, which is equivalent to 200 mg of cefpodoxime. Blood and lung tissue samples were collected during surgery, and bronchoalveolar lavage was carried out 3 h (group A) or 6 h (group B) after drug administration. Urea was used as an endogenous marker for measurement of the volume of epithelial lining fluid (ELF). Concentrations were measured by using a microbiological assay. The mean concentrations of cefpodoxime in plasma, ELF, and lung tissue were, respectively, 1.85 +/- 0.82 mg/liter, 0.22 +/- 0.13 mg/liter, and 0.89 +/- 0.80 mg/kg of body weight in group A and 1.40 +/- 1.25 mg/liter, 0.12 +/- 0.14 mg/liter, and 0.84 +/- 0.61 mg/kg in group B. Concentrations in lung parenchyma 6 h after dosing were at least equal to or above the MICs for 90% of the strains of most organisms commonly found in respiratory tract infections, whereas data for ELF suggest levels of drug insufficient to inhibit bacteria. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1128/aac.36.10.2099 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1128/AAC.36.10.2099 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://dx.doi.org/10.1128/aac.36.10.2099<br />https://journals.asm.org/doi/pdf/10.1128/AAC.36.10.2099 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://journals.asm.org/non-commercial-tdm-license ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.6A6D5847 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1128/aac.36.10.2099
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Muller-Serieys, C
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bancal, C
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Dombret, M C
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Soler, P
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Murciano, G
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Aubier, M
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bergogne-Berezin, E
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 1992
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Antimicrobial Agents and Chemotherapy ; volume 36, issue 10, page 2099-2103 ; ISSN 0066-4804 1098-6596
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |